A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 7, 2009

Primary Completion Date

July 29, 2010

Study Completion Date

July 29, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

PF-04171327 10 mg

PF-04171327 10 mg tablet every day for 14 days

OTHER

Prednisone Placebo

Placebo for Prednisone 5 mg tablet every day for 14 days

DRUG

PF-04171327 25 mg

PF-04171327 25 mg tablet every day for 14 days

OTHER

Prednisone Placebo

Placebo for Prednisone 5 mg tablet every day for 14 days

DRUG

Prednisone 5 mg

Prednisone 5 mg tablet every day for 14 days

OTHER

Placebo for PF-04171327

Placebo for PF-04171327 every day for 14 days

OTHER

Placebo

Placebo tablet every day for 14 days

OTHER

Placebo for PF-04171327

Placebo tablet every day for 14 days

Trial Locations (41)

407

Taichung Veterans General Hospital, Taichung

4032

Debreceni Egyetem Orvos és Egeszsegtudomanyi Centrum, Debrecen

5600

Dr. Rethy Pal Korhaz es Rendelointezet\Reumatologia, Békéscsaba

11000

Institute of Rheumatology, Belgrade

15705

Hospital Nuestra Señora de La Esperanza, Santiago de Compostela

16635

Altoona Center for Clinical Research, Duncansville

18205

Institute for Rheumatic and Cardiovascular Disease Niska Banja, Niška Banja

21018

Vinnitsa Regional Clinical Hospital n.a. Pirogov, Vinnitsa

32114

Allergy, Asthma, Arthritis and Lung, Daytona Beach

32174

Millennium Research, Ormond Beach

33169

Elite Research Institute, Miami

33542

Florida Medical Clinic, PA, Zephyrhills

36207

Anniston Medical Clinic, PC, Anniston

Pinnacle Research Group, LLC, Anniston

41009

Hospital Universitario Virgen Macarena, Seville

48013

Hospital de Basurto, Bilbao

48025

Premier Imaging Center, Bingham Farms

Quest Research Institute, Bingham Farms

48903

Hospital de Cruces, Barakaldo

61176

Chair of Cardiology & Functional Diagnostic, Kharkiv

62704

The Arthritis Center, Springfield

79011

Municipal City Clinical Hospital #4, Department of Rheumatology, Lviv

115093

Moscow SHI City Clinical Hospital #4, Department of Therapy of Moscow Faculty, Moscow

115522

Institution of Russian Academy of Medical Sciences Research Institute of Rheumatology RAMS, Moscow

192242

SI Saint-Petersburg SRI for Emergency Care named after I.I. Dzhanelidze, Saint Petersburg

214018

Regional State Institution of Healthcare Smolensk Regional Clinical Hospital, Smolensk

529889

Changi General Hospital, Singapore

370 01

MEDIPONT Plus, s.r.o., České Budějovice

253 01

ARTMEDI UPD s r.o., Hostivice

140 00

Revmatologicka ambulance, Prague

140 59

Fakultni Thomayerova nemocnice s poliklinikou, Prague

148 00

DC Mediscan, Praha 11 - Chodov

Unknown

Centre for Assessment and Treatment of Rheumatic Diseases, Department of Medicine and Geriatrics, New Territories

H-1036

Synexus Magyarorszag Kft., Budapest

H-5000

MAV Korhaz es Rendelointezet, Szolnok

921 12

Narodny ustav reumatickych chorob, Klinicke oddelenie, Piešťany

010 01

Nestatna reumatologicka ambulancia, MUDr. Pavol Polak, s.r.o., Žilina

120-752

Severance Hospital, Yonsei University College of Medicine, Rheumatology, Internal Medicine, Seoul

06100

Ankara University School fo Medicine, Ankara

04114

"State Institution Institute of Gerontology of AMS of Ukraine", Kyiv

State Institution 'Institute of Gerontology of AMS of Ukraine', Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00938587 - A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter